Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.48 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.46 |
| ▸ | TUBB | P07437 | 3/20 | 0.46 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.46 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.46 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.46 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.46 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.46 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.46 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.46 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.46 |
| ▸ | TUBA1A | Q71U36 | 3/20 | 0.46 |
| ▸ | TUBA1C | Q9BQE3 | 3/20 | 0.46 |
| ▸ | TUBB6 | Q9BUF5 | 3/20 | 0.46 |
| ▸ | TUBB2B | Q9BVA1 | 3/20 | 0.46 |
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.43 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12118475 | 0.85 | TRPV1 (0.52) | ENPP2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL29957898 | 0.85 | TRPV1 (0.52) | ENPP2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL29588618 | 0.83 | ENPP2 (0.47) | ENPP2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL319585 | 0.83 | ENPP2 (0.47) | ENPP2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL15674823 | 0.81 | EGFR (0.48) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL29952486 | 0.80 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2HPGDALOX15HSD17B10 | |
| SCHEMBL31063492 | 0.80 | ENPP2 (0.41) | ENPP2TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL29436012 | 0.77 | CA2 (0.50) | ALDH1A1SMN1; SMN2TRPV1HPGDALOX15 | |
| SCHEMBL179467 | 0.77 | CA2 (0.50) | ALDH1A1SMN1; SMN2TRPV1HPGDALOX15 | |
| SCHEMBL7978272 | 0.76 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2HPGDALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115197254-A | Nitrogen boron nitrogen hetero-bispiro alkene containing (HN) -B- (NH) structure, eutectic assembly and preparation method thereof | 上海交通大学 | 2022-10-18 | — | — | CN | claimed |
| CN-119798292-A | Polycyclic fusion molecule containing oxygen, boron and nitrogen coordination bonds and preparation method thereof | 华侨大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-115197254-B | Nitrogen boron nitrogen hetero-bisspiroalkene containing (HN) -B- (NH) structure, eutectic assembly thereof and preparation method | 上海交通大学 | 2024-09-20 | — | — | CN | disclosed |
| US-11785840-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnosis composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-115197254-A | Nitrogen boron nitrogen hetero-bispiro alkene containing (HN) -B- (NH) structure, eutectic assembly and preparation method thereof | 上海交通大学 | 2022-10-18 | — | — | CN | disclosed |
| US-20210226135-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSIS COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2021-07-22 | — | — | US | disclosed |
| US-11011711-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnosis composition incluidng the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-05-18 | — | — | US | disclosed |
| US-10954251-B2 | Thienopyrimidine inhibitors of atypical protein kinase C | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2021-03-23 | — | — | US | disclosed |
| CN-107056844-B | Organometallic compound, organic light emitting device including the same, and diagnostic composition including the same | 三星电子株式会社 | 2021-03-16 | — | — | CN | disclosed |
| US-20100105909-A1 | MODIFIED METAL COMPLEX AND USE THEREOF | SUMITTO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-29 | — | — | US | disclosed |
| WO-2010010017-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-01-28 | — | — | WO | disclosed |
| US-20100021423-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2010-01-28 | — | — | US | disclosed |
| WO-2009098282-A1 | LOW MOLECULAR WEIGHT 2,5-DISUBSTITUTED THIOPHENE DERIVATIVES AND USE THEREOF IN THERAPY | NOVASAID AB (SE) | 2009-08-13 | — | — | WO | disclosed |
| WO-2009053694-A1 | THERAPEUTIC OXY-PHENYL-ARYL COMPOUNDS AND THEIR USE | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2009-04-30 | — | — | WO | disclosed |
| US-20090042892-A1 | Cetp Inhibitors | MERCK SHARP & DOHME LLC | 2009-02-12 | — | — | US | disclosed |
| US-20090042892-A1 | Cetp Inhibitors | MERCK SHARP & DOHME LLC | 2009-02-12 | — | — | US | disclosed |
| US-20090018054-A1 | Cholesteryl Ester Transfer Protein Inhibitors | MERCK SHARP & DOHME LLC | 2009-01-15 | — | — | US | disclosed |
| EP-1973546-A2 | CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | Merck & Co., Inc. (US) | 2008-10-01 | — | — | EP | disclosed |
| WO-2007081570-A2 | CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS | MERCK & CO., INC. (US) | 2007-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042892-A1 | Cetp Inhibitors | CETP, APOB, MTTP | ENPP2 2659/4885TUBB4A 2214/4885TUBB 1875/4885 |
| US-20210226135-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSIS COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | OCIAD1, ORC3, LEF1 | ENPP2 4196/4885TUBB4A 3007/4885TUBB 3283/4885 |
| US-11785840-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnosis composition including the organometallic compound | OCIAD1, ORC3, LEF1 | ENPP2 4196/4885TUBB4A 3007/4885TUBB 3283/4885 |
| US-10954251-B2 | Thienopyrimidine inhibitors of atypical protein kinase C | PRKX, PRKCQ, PRKACA | ENPP2 1661/4885TUBB4A 2508/4885TUBB 2633/4885 |
| US-20100105909-A1 | MODIFIED METAL COMPLEX AND USE THEREOF | TPR, MT-CO2, AP3M1 | ENPP2 4685/4885TUBB4A 2898/4885TUBB 3207/4885 |
| US-20090018054-A1 | Cholesteryl Ester Transfer Protein Inhibitors | CETP, APOB, MTTP | ENPP2 2101/4885TUBB4A 2323/4885TUBB 2798/4885 |
| US-20100021423-A1 | Heterocyclic antiviral compounds | POLR2A, RRM2B, RRP1B | ENPP2 4335/4885TUBB4A 1164/4885TUBB 1243/4885 |
| US-11011711-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnosis composition incluidng the organometallic compound | OCIAD1, OCIAD2, PDCD1LG2 | ENPP2 4487/4885TUBB4A 2389/4885TUBB 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.